Exelixis, Inc. (EXEL) - NASDAQ
  • Alexander Valtsev | Send Message 20 Jul

    Five Stocks to Buy and Hold for the Next Decade: http://bit.ly/200716EXEL $EXEL $NVDA $WM $PEP $AMD $IBM $BMY
      • Bret Jensen | Send Message 18 Jul

        3 Small, Attractive Biotech Stocks With Upcoming Catalysts $EGLT, $EXEL, $NVAX http://seekingalpha.com/p/2x14p
          • StockConsultant | Send Message 18 Jul

            Notable breakout watch stocks $DO $LXRX $AAP $CLR $EXEL $HBM $IMGR $NYLD $OUTR $PAGP $SUPN $TWOU analysis and charts at http://chart.st?DO
              • Market Newsletter | Send Message 15 Jul

                PennyStocksDeal's Results: $EXEL opened LONG on 7/14 at $8.00 and closed today's at $8.40 +5.00% pennystocksdeal
                  • Bret Jensen | Send Message 14 Jul

                    Behind Small Biotech Exelixis' Huge Rally & What To Do Now $EXEL http://seekingalpha.com/p/2x0ec
                      • Lowenthal Capital Partners | Send Message 13 Jul

                        With Or Without A Near-Term Buyout, Here's Why Exelixis Presents A Golden Buying Opportunity $EXEL http://seekingalpha.com/a/2dhb0
                          • Ramiz Bozai | Send Message 11 Jul

                            Exelixis' Cabometyx Is Well-Positioned To Compete With Opdivo In Advanced Renal Cell Carcinoma $EXEL http://seekingalpha.com/a/2dgrc
                              • Alexander Valtsev | Send Message 8 Jul

                                The Reason Why Exelixis Skyrocketed 20.5% in June: http://bit.ly/29A1j5r $EXEL $BMY
                                  • Eric Muathe | Send Message 2 Jul

                                    [ VIDEO ] Wknd US Mrkt Analysis July 02, 2016 $MU $BAC $F $RAD $CHK $GE $FCX $AAPL $T $HOG $X $MSFT $EXEL $WLL http://bit.ly/29csFz2
                                      • wilkinson99 | Send Message 21 Jun

                                        Price Targets Raise 06/21 for $EGN $EXEL $HAL $ONCE $OTEX while $HHS $NKE $WERN had respective Price Targets Lowered
                                          Company Description
                                          Exelixis, Inc. is a biopharmaceutical company, which engages in the developing and commercializing small molecule therapies for the treatment of cancer. Its two advanced assets are COMETRIQ and cobimetinib. The company focuses on their proprietary resources and development and commercialization... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States